Ultragenyx Pharmaceutical (RARE) Q3 2023 Earnings

3AugConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-3.5
-3.01
-2.53
-2.04

Details

Expected EPS
-2.08
Actual EPS
-2.25
Surprise EPS
-0.17
Surprise Percent
+8.17%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -2.25 per share for Q3 2023.

0 Comments

Share your thoughts